Vonoprazan
EoE-201
Phase 2 small_molecule active
Quick answer
Vonoprazan for Eosinophilic Esophagitis is a Phase 2 program (small_molecule) at Phathom Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Phathom Pharmaceuticals
- Indication
- Eosinophilic Esophagitis
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active